
The National Institute of Mental Health has granted researchers at the University of Pennsylvania School of Nursing and New York Blood Center $769,578 to go towards efforts to create an HIV awareness program for women.


The National Institute of Mental Health has granted researchers at the University of Pennsylvania School of Nursing and New York Blood Center $769,578 to go towards efforts to create an HIV awareness program for women.

Buyers clubs are still going strong in the United States and around the world as the offer a low-cost alternative for individuals with HIV and hepatitis c virus (HCV) who often find themselves struggling to pay for the expensive medications they need to treat their illness.

At the Centers for Disease Control and Prevention's 2016 STD Prevention Conference, researchers discussed three novel prevention strategies for HIV, other STIs, and unintended pregnancies.

Technology gives men who have sex with men (MSM) new ways to assess their health status, prevent HIV and other STDs (sexually transmitted diseases), and find care.

New prevention and treatment models are needed worldwide and one such model is the Dean Street Express Clinic in London, England.

A new test that can effectively estimate HIV-negative patients’ adherence to prescribed drugs to prevent the transmission of human immunodeficiency virus (HIV) during sexual intercourse has been discovered by researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz.

David Rosenthal, DO, PhD, medical director at the Center for Young Adult, Adolescent and Pediatric HIV Care at Northwell Health, reflects on a JAMA study, which states that use of antiretroviral therapy reduced the risk of HIV transmission during condomless sex.

The number of physicians and nurse practitioners aware of HIV pre-exposure prophylaxis (PrEP) and its potential benefits has increased dramatically in the years since it was first introduced to the market.

This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.